Indian J Pharm Close
 

Table 17: Question 5 (i): Assuming absence of visceral crisis, what is the most appropriate choice of therapy for pre‑menopausal patients with newly diagnosed stage IV de novo HR +ve/Her2 – ve breast cancer?

Table 17: Question 5 (i): Assuming absence of visceral crisis, what is the most appropriate choice of therapy
for pre‑menopausal patients with newly diagnosed stage IV <i>de novo</i> HR +ve/Her2 – ve breast cancer?